Delivery Order SPE2DB22D3501-SPE2DB25FVM98

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,955,772 tablets of the medication Clobazam 10 mg, with a total ceiling value of $7,593.04. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 18, 2025. This order is not associated with any set-aside program and was competitively...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,094,847 Clobazam 10 mg tablets, valued at $4,682.65. The contract has an ultimate completion date of December 14, 2023 and uses a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,888,596 units of the drug clobazam 10 mg tablets. The contract has a ceiling value of $17,460.60 and a completion date of April 14, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,089,523 units of the medication clobazam 10 mg tablet, with a ceiling value of $3,163.46 and a completion date of July 9, 2024. The contract is a firm fixed-price, delivery order type and was not set aside for any particular business category. AmerisourceBergen Drug Corp, a for-profit organization, is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,003.37 firm fixed-price contract is for the supply of 4,565,661,141 units of the prescription medication Clobazam 10 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,935.11 firm fixed-price contract is for the supply of 4,563,131,211 units of the medication clobazam 10 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Clobazam 10 mg tablets, a pharmaceutical product used for medical treatment. The contract has a firm fixed price of $8,056.03 and a completion date of June 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,340 units of the pharmaceutical product Clobazam 10 mg Tablet. The contract has a firm fixed price of $5,708.85 and a completion date of April 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order, valued at $2,395.31, is for the supply of 4,563,970,516 units of clobazam 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,086 units of the drug clobazam 10 mg tablets. The contract has a ceiling value of $1,564.87 and a period of performance through July 9, 2024. It is a firm fixed-price contract and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVM98
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,108,772 units of the prescription medication Clobazam 10 mg tablets. The contract has a firm fixed price of $1,713.47 and a completion date of May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is open to full and open competition.

Generated 7/31/25, 9:49 AM